Form 4: Quaker Chemical Director Charlotte Henry Reports Routine Equity Compensation Transactions

Quaker Chemical Corp. Director Charlotte C. Henry reported the vesting of 716 restricted stock units and related dividend equivalent rights, converting them into common stock, and the grant of 1,198 new restricted stock units as part of her 2025 compensation.

Summary

• Charlotte C. Henry, a Director of Quaker Chemical Corp. (KWR), reported changes in her beneficial ownership of company securities.
• On May 31, 2025, 716 restricted stock units (RSUs) and 9 dividend equivalent rights (DERs) vested and converted into common stock.
• These 716 RSUs were originally granted on June 1, 2024, and vested 100% on May 31, 2025.
• The DERs settled in connection with the RSU vesting, with each right equivalent to one share of KWR common stock.
• Following these transactions, Henry's direct beneficial ownership of common stock increased by 725 shares (716 + 9), reaching a total of 3,271 shares.
• Additionally, on June 1, 2025, Henry was granted 1,198 new time-based restricted stock units under the company's Long-Term Performance Incentive Plan as part of her 2025 non-executive director compensation.
• These new 1,198 RSUs are expected to vest 100% on May 31, 2026, and will accrue dividend equivalent rights.

Sentiment

Score: 7

Explanation: The document reports routine, positive events for the director (vesting of existing equity, grant of new equity), which aligns director interests with shareholders. There are no negative or concerning elements reported.

Positives

• The grant of 1,198 new restricted stock units aligns the director's interests with long-term shareholder value.
• The vesting of previously granted restricted stock units demonstrates the company's commitment to its equity compensation plan for directors.

Future Outlook

Charlotte C. Henry was granted 1,198 new time-based restricted stock units that are expected to vest 100% on May 31, 2026, indicating future equity compensation.

Industry Context

This Form 4 filing details routine equity compensation for a director, which is a standard practice across publicly traded companies to align executive and director interests with shareholder value. It does not provide specific industry-wide trends or competitive insights.

Comparison to Industry Standards

• The reported transactions, involving the vesting and grant of restricted stock units, are standard practices for non-executive director compensation in publicly traded companies.
• While specific comparable companies or projects are not detailed in this filing, equity-based compensation is a common mechanism used by companies like DuPont, PPG Industries, and Sherwin-Williams (competitors or peers in the specialty chemicals sector) to incentivize and retain directors and executives, aligning their interests with long-term company performance and shareholder returns.
• The structure of time-based vesting is typical for such grants.

Stakeholder Impact

• Shareholders: The transactions represent routine equity compensation for a director, aligning her interests with long-term shareholder value. The increase in common stock ownership by a director can be seen as a positive signal of confidence.

Next Steps

• The 1,198 restricted stock units granted on June 1, 2025, are expected to vest 100% on May 31, 2026.
• Dividend equivalent rights will accrue on these new RSUs when dividends are paid on KWR common stock.

Key Dates

Keywords

Quaker Chemical Corp, KWR, Form 4, SEC filing, insider transaction, restricted stock units, equity compensation, director compensation, beneficial ownership, dividend equivalent rights